- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01236131
The Role of Novel Organisms in Acute Endometritis
August 15, 2016 updated by: Sharon Hillier
Characterization of Novel Organisms in the Genital Tract of Women With PID and Determination of Their Association With Endometritis.
The goal of this project is to identify the microorganisms present in the endometrial samples obtained from women with or without evidence of endometritis using a combination of culture methods, rRNA sequencing and whole genomic sequencing.
The overarching aim of these studies is to identify the etiology of endometritis.
The investigators will define the role of fastidious anaerobic microorganisms in the etiology of PID, and assess whether antibiotic treatment regimens used for the treatment of PID have activity against the novel organisms linked with pelvic infections.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
480
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15213
- Magee-Womens Research Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
15 years to 40 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Endometrial biopsy samples from women participating in University of Pittsburgh IRB PRO10010112 and PRO10010159
Description
Inclusion Criteria:
- This is a laboratory research study involving the use of biologic specimens only.
- Specimens (endometrial biopsy samples) collected from subjects who meet the inclusion criteria for PRO10010159 and PRO10010112 will be utilized for this study.
Exclusion Criteria:
- Specimens (endometrial biopsy samples) that are collected from subjects enrolled in PRO10010159 and PRO10010112 that are insufficient will not be included in this study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Endometrial biospy samples
The Endometrial Biopsy samples will be provided by women enrolled in the University of Pittsburgh IRB PRO10010112 and PRO10010159
|
Not Applicable- no intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Identification of Novel Organsims from PRO10010159
Time Frame: 12 months after participant enrollment in PRO10010159
|
This study will use optimized culture methods which can support the growth of fastidious organisms to describe the microorganisms in endometrial tissue samples obtained from the 200 women enrolled in the cervicitis cohort (PRO10010159, T Cell Response).
|
12 months after participant enrollment in PRO10010159
|
Identification of Novel Organisms from PRO10010112
Time Frame: 30 days after participant enrollment in PRO10010112
|
This study will use optimized culture methods which can support the growth of fastidious organisms to describe the microorganisms in endometrial tissue samples obtained from 250 women enrolled in the acute PID study before and after treatment (PRO10010112, Acute PID treatment).
|
30 days after participant enrollment in PRO10010112
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2010
Primary Completion (Actual)
August 1, 2015
Study Completion (Actual)
August 1, 2015
Study Registration Dates
First Submitted
November 4, 2010
First Submitted That Met QC Criteria
November 5, 2010
First Posted (Estimate)
November 7, 2010
Study Record Updates
Last Update Posted (Estimate)
August 17, 2016
Last Update Submitted That Met QC Criteria
August 15, 2016
Last Verified
August 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PRO10080491
- 1U19AI084024-01 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pelvic Inflammatory Disease
-
Kangbuk Samsung HospitalRecruiting
-
Johns Hopkins UniversityNational Institute of Nursing Research (NINR)CompletedPelvic Inflammatory Disease (PID)United States
-
China Academy of Chinese Medical SciencesPeking University First Hospital; Peking Union Medical College Hospital; Chengdu... and other collaboratorsUnknown
-
China Academy of Chinese Medical SciencesPeking University First Hospital; Peking Union Medical College Hospital; Chengdu... and other collaboratorsUnknown
-
RAPbarcelonaCompletedChronic Pain | Pelvic Pain | Physical Therapy | Chronic Pain Syndrome | Pelvic Pain Syndrome | Chronic Pelvic Inflammatory DiseaseSpain
-
The University of Hong KongCompletedSexually Transmitted Infections | Induced Abortion | Postaboral Pelvic Inflammatory DiseaseChina
-
Children's Hospital of PhiladelphiaCompletedPelvic Inflammatory DiseaseUnited States
-
University of KarachiZhuzhou Qianjin Pharmaceutical Co., Ltd., 801, Zhuzhou, China; Center for bioequivalence...CompletedPelvic Inflammatory DiseasePakistan
-
Shanghai University of Traditional Chinese MedicineUnknown
-
BayerCompletedPelvic Inflammatory DiseaseGermany, Italy, France, Hungary, Sweden, Poland, South Africa, Russian Federation, Finland, Denmark, Lithuania, United Kingdom, Greece
Clinical Trials on no intervention
-
Wave NeuroscienceCompletedAutistic DisorderUnited States
-
University of Alabama at BirminghamCompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social BehaviorUnited States
-
Janssen Research & Development, LLCCompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous | Lupus Erythematosus, DiscoidUnited States, Poland
-
Hospital Universitario La Paz3MVX CCB and Agaplesion Markus Krankenhaus, Frankfurt a.M., Germany.; Department...RecruitingEmbolism | Atrial Fibrillation | Arrhythmia | Stroke, Acute | Stroke Sequelae | AblationSpain
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
University of Dublin, Trinity CollegeCompleted
-
Hôpital Necker-Enfants MaladesUnknown
-
China Medical University HospitalUnknownIntention to Stay, Turnover Behavior
-
Wright State UniversityCompleted